Identification of Potent and Long-Acting Single-Chain Peptide Mimetics of Human Relaxin-2 for Cardiovascular Diseases
Sergio Mallart(Sanofi (France)), Stéphane Illiano(Délégation Paris 5), Isabelle Menguy(Sanofi (France)), Philip Janiak(Hôpital Lariboisière), Laura Orsatti(IRBM Science Park), Alain Corbier(Sanofi (France)), Frank Marguet(Sanofi (France)), Alexandre Raux(Sanofi (France)), Daniela Roversi(IRBM Science Park), Claire Minoletti(Sanofi (France)), Denis Brasseur(Sanofi (France)), Olivier Duclos(Sanofi (France)), Edith Monteagudo(IRBM Science Park), Bruno Poirier(Sanofi (France)), Mariana Gallo(University of Parma), Régine Bartsch(Sanofi (France)), Federica Tucci(IRBM Science Park), Jacques Froissant(Sanofi (France)), Laurence Gauzy‐Lazo(Sanofi (France)), Maria Veneziano(IRBM Science Park), Raffaele Ingenito, Elisabetta Bianchi(IRBM Science Park), Alessia Santoprete(IRBM Science Park), Vincent Gervat(Sanofi (France)), Alberto Bresciani(University of Bergamo), Patricia Bruneau(Sanofi (France)), Laurence Riva(Sanofi (France)), Paola Magotti(IRBM Science Park), Hartmut Strobel(IRBM Science Park), Olivier Pasquier(Sanofi (France)), Marie-Françoise Nicolas(Sanofi (France)), Claudius Boehm(Sanofi (Germany)), Simone Esposito(IRBM Science Park)
Cited by 29
Related Papers
A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope
|Proceedings of the National Academy of Sciences|2005|156
Adipogenesis of skeletal muscle fibro/adipogenic progenitors is affected by the WNT5a/GSK3/β-catenin axis
|Cell Death and Differentiation|2020|149
Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein Receptor
|Circulation|2023|141
Inhibiting pathologically active ADAM10 rescues synaptic and cognitive decline in Huntington’s disease
|Journal of Clinical Investigation|2019|101
Angiotensin AT1 Receptor Antagonist Irbesartan Decreases Lesion Size, Chemokine Expression, and Macrophage Accumulation in Apolipoprotein E-Deficient Mice
|Journal of Cardiovascular Pharmacology|2001|93